Cargando…

低剂量螺旋CT在肺癌筛查中的应用

Lung cancer is one of the malignant tumors with the highest morbidity and mortality in the world. The low early diagnosis rate and poor prognosis of patients have caused serious social burden. Regular screening of high-risk population by low-dose spiral computed tomography (LDCT) can significantly i...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 中国肺癌杂志编辑部 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9549430/
https://www.ncbi.nlm.nih.gov/pubmed/36172733
http://dx.doi.org/10.3779/j.issn.1009-3419.2022.101.40
_version_ 1784805669922144256
collection PubMed
description Lung cancer is one of the malignant tumors with the highest morbidity and mortality in the world. The low early diagnosis rate and poor prognosis of patients have caused serious social burden. Regular screening of high-risk population by low-dose spiral computed tomography (LDCT) can significantly improve the early diagnosis rate of lung cancer and bring new opportunities for the diagnosis and treatment of lung cancer. In recent years, LDCT lung cancer screening programs have been carried out in many countries around the world and achieved good results, but there are still some controversies in the selection of screening subjects, screening frequency, cost effectiveness and other aspects. In this paper, the key factors of LDCT lung cancer screening, screening effect, pulmonary nodule management and artificial intelligence contribution to the development of LDCT will be reviewed, and the application progress of LDCT in lung cancer screening will be discussed.
format Online
Article
Text
id pubmed-9549430
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher 中国肺癌杂志编辑部
record_format MEDLINE/PubMed
spelling pubmed-95494302022-10-24 低剂量螺旋CT在肺癌筛查中的应用 Zhongguo Fei Ai Za Zhi 综述 Lung cancer is one of the malignant tumors with the highest morbidity and mortality in the world. The low early diagnosis rate and poor prognosis of patients have caused serious social burden. Regular screening of high-risk population by low-dose spiral computed tomography (LDCT) can significantly improve the early diagnosis rate of lung cancer and bring new opportunities for the diagnosis and treatment of lung cancer. In recent years, LDCT lung cancer screening programs have been carried out in many countries around the world and achieved good results, but there are still some controversies in the selection of screening subjects, screening frequency, cost effectiveness and other aspects. In this paper, the key factors of LDCT lung cancer screening, screening effect, pulmonary nodule management and artificial intelligence contribution to the development of LDCT will be reviewed, and the application progress of LDCT in lung cancer screening will be discussed. 中国肺癌杂志编辑部 2022-09-20 /pmc/articles/PMC9549430/ /pubmed/36172733 http://dx.doi.org/10.3779/j.issn.1009-3419.2022.101.40 Text en 版权所有©《中国肺癌杂志》编辑部2022 https://creativecommons.org/licenses/by/3.0/This is an open access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 3.0) License. See: https://creativecommons.org/licenses/by/3.0/.
spellingShingle 综述
低剂量螺旋CT在肺癌筛查中的应用
title 低剂量螺旋CT在肺癌筛查中的应用
title_full 低剂量螺旋CT在肺癌筛查中的应用
title_fullStr 低剂量螺旋CT在肺癌筛查中的应用
title_full_unstemmed 低剂量螺旋CT在肺癌筛查中的应用
title_short 低剂量螺旋CT在肺癌筛查中的应用
title_sort 低剂量螺旋ct在肺癌筛查中的应用
topic 综述
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9549430/
https://www.ncbi.nlm.nih.gov/pubmed/36172733
http://dx.doi.org/10.3779/j.issn.1009-3419.2022.101.40
work_keys_str_mv AT dījìliàngluóxuánctzàifèiáishāicházhōngdeyīngyòng
AT dījìliàngluóxuánctzàifèiáishāicházhōngdeyīngyòng
AT dījìliàngluóxuánctzàifèiáishāicházhōngdeyīngyòng
AT dījìliàngluóxuánctzàifèiáishāicházhōngdeyīngyòng